🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchAnyone else refreshing ClinicalTrials.gov every morning or just me Page 3

Anyone else refreshing ClinicalTrials.gov every morning or just me

TrialNerd_Beth Thu, Apr 30, 2026 at 8:30 AM 22 replies 944 viewsPage 3 of 5
PurityPaulOR
Senior Member
1,890
7,890
Mar 2024
Oregon
May 1, 2026 at 3:20 PM#11
Dr.DermMIA said:
anders_CPH said: ...regarding the trial evidence...

Dr.DermMIA has the substance of this right. The condition it depends on is worth stating. Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.

Last edited: May 1, 2026 at 6:20 PM
10 10Dr.LeslieOBGYN, MikeNYC_runner and 7 others
Reply Quote Save Share Report
RickReta_CO
Member
312
1,234
Jan 2025
Colorado
May 2, 2026 at 8:41 AM#12
Dr.SportsMedIN said:
Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals.

Genuinely useful, thank you. I had the facts and not the framework.

9 9jim_asheville, matt_MKE, Dr.ReproEndo and 6 others
Reply Quote Save Share Report
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
May 3, 2026 at 2:03 AM#13
Dr.DermMIA said:
anders_CPH said: ...regarding the trial evidence...

Pushing back on Dr.DermMIA here. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

Last edited: May 3, 2026 at 6:03 AM
8 8LarryQC_SD, wanda_boise, NurseAsh_DET and 5 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
May 3, 2026 at 7:25 PM#14

One concrete data point for the thread. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

7 7andrew_nyc, Dr.EndoEP, GraceAZ_72 and 4 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
May 4, 2026 at 12:48 PM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source.

6 6PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 3 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register